—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Liquidia Technologies Inc（LQDA）— 同类公司组

数据截至2026-10-29 — 评分每个交易日晚间重新计算。分组标准＝首先为共同的Closelook指数成分，其次为行业。Closelook研究日记，不构成投资建议。

Liquidia Technologies Inc的Closelook综合评分为47/100，在同类公司组内排名第7位（共7家）——组内评分最高的是Laboratorios Farmaceuticos ROVI（62/100）。

名称综合动量质量估值信号距52周高点
LQDA Liquidia Technologies Inc47336831info51.9%
ROVI.MC Laboratorios Farmaceuticos ROVI62347750info27.8%
LNTH Lantheus Holdings Inc60727454ok10.3%
BHC.TO Bausch Health Companies Inc58927182info1.9%
GALDY GALDERMA GROUP AG57706022info1.6%
KNSA Kiniksa Pharmaceuticals Ltd57975918ok0.8%
AMRX Amneal Pharmaceuticals, Inc. Class A Common Stock56935846ok1.5%

评分为Closelook全部覆盖范围内的相对读数——方法论见公司评分说明。信号灯来自每日夜间信号看板。

FAQ · from the current data · as of 2026-10-29

Quick answers

Liquidia Technologies Inc在Closelook覆盖范围内的同类公司有哪些？

分组首先基于共同的Closelook指数成分，其次基于行业：Laboratorios Farmaceuticos ROVI (ROVI.MC)、Lantheus Holdings Inc (LNTH)、Bausch Health Companies Inc (BHC.TO)、GALDERMA GROUP AG (GALDY)、Kiniksa Pharmaceuticals Ltd (KNSA)、Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX)。

LQDA相对同类公司的评分如何？

Liquidia Technologies Inc的综合评分为47/100，组内排名第7位（共7家），截至2026-10-29；组内最高综合评分为Laboratorios Farmaceuticos ROVI（62/100）。Closelook评分为研究日记读数，不构成评级或投资建议。

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.